View Future GrowthFuva Brain 過去の業績過去 基準チェック /46Fuva Brainは、平均年間80.9%の収益成長を遂げていますが、 Software業界の収益は、年間 成長しています。収益は、平均年間13.5% 30.5%収益成長率で 成長しています。 Fuva Brainの自己資本利益率は14.6%であり、純利益率は5.5%です。主要情報80.86%収益成長率80.73%EPS成長率Software 業界の成長12.13%収益成長率30.50%株主資本利益率14.60%ネット・マージン5.46%前回の決算情報31 Mar 2026最近の業績更新Reported Earnings • May 20Full year 2026 earnings released: EPS: JP¥57.63 (vs JP¥20.66 in FY 2025)Full year 2026 results: EPS: JP¥57.63 (up from JP¥20.66 in FY 2025). Revenue: JP¥5.64b (up 29% from FY 2025). Net income: JP¥308.0m (up 183% from FY 2025). Profit margin: 5.5% (up from 2.5% in FY 2025). Over the last 3 years on average, earnings per share has increased by 103% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.Reported Earnings • Feb 16Third quarter 2026 earnings released: EPS: JP¥8.42 (vs JP¥5.26 in 3Q 2025)Third quarter 2026 results: EPS: JP¥8.42 (up from JP¥5.26 in 3Q 2025). Revenue: JP¥1.43b (up 18% from 3Q 2025). Net income: JP¥45.0m (up 61% from 3Q 2025). Profit margin: 3.1% (up from 2.3% in 3Q 2025). Over the last 3 years on average, earnings per share has increased by 105% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth.お知らせ • Dec 02Fuva Brain Limited to Report Q3, 2026 Results on Feb 13, 2026Fuva Brain Limited announced that they will report Q3, 2026 results on Feb 13, 2026分析記事 • Nov 23Statutory Earnings May Not Be The Best Way To Understand Fuva Brain's (TSE:3927) True PositionDespite posting strong earnings, Fuva Brain Limited's ( TSE:3927 ) stock didn't move much over the last week. We looked...お知らせ • Sep 01Fuva Brain Limited to Report Q2, 2026 Results on Nov 14, 2025Fuva Brain Limited announced that they will report Q2, 2026 results on Nov 14, 2025Reported Earnings • Aug 16First quarter 2026 earnings released: EPS: JP¥45.84 (vs JP¥0.57 loss in 1Q 2025)First quarter 2026 results: EPS: JP¥45.84 (up from JP¥0.57 loss in 1Q 2025). Revenue: JP¥1.30b (up 36% from 1Q 2025). Net income: JP¥245.0m (up JP¥248.0m from 1Q 2025). Profit margin: 19% (up from net loss in 1Q 2025). Over the last 3 years on average, earnings per share has increased by 83% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.すべての更新を表示Recent updatesReported Earnings • May 20Full year 2026 earnings released: EPS: JP¥57.63 (vs JP¥20.66 in FY 2025)Full year 2026 results: EPS: JP¥57.63 (up from JP¥20.66 in FY 2025). Revenue: JP¥5.64b (up 29% from FY 2025). Net income: JP¥308.0m (up 183% from FY 2025). Profit margin: 5.5% (up from 2.5% in FY 2025). Over the last 3 years on average, earnings per share has increased by 103% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.New Risk • May 18New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Japanese stocks, typically moving 9.5% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (9.5% average weekly change). Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (JP¥5.34b market cap, or US$33.7m).お知らせ • May 15Fuva Brain Limited, Annual General Meeting, Jun 24, 2026Fuva Brain Limited, Annual General Meeting, Jun 24, 2026.Valuation Update With 7 Day Price Move • May 11Investor sentiment improves as stock rises 17%After last week's 17% share price gain to JP¥1,197, the stock trades at a trailing P/E ratio of 15.2x. Average trailing P/E is 17x in the Software industry in Japan. Total returns to shareholders of 101% over the past three years.Valuation Update With 7 Day Price Move • Mar 10Investor sentiment improves as stock rises 25%After last week's 25% share price gain to JP¥1,049, the stock trades at a trailing P/E ratio of 13.3x. Average trailing P/E is 17x in the Software industry in Japan. Total returns to shareholders of 69% over the past three years.Reported Earnings • Feb 16Third quarter 2026 earnings released: EPS: JP¥8.42 (vs JP¥5.26 in 3Q 2025)Third quarter 2026 results: EPS: JP¥8.42 (up from JP¥5.26 in 3Q 2025). Revenue: JP¥1.43b (up 18% from 3Q 2025). Net income: JP¥45.0m (up 61% from 3Q 2025). Profit margin: 3.1% (up from 2.3% in 3Q 2025). Over the last 3 years on average, earnings per share has increased by 105% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth.お知らせ • Dec 02Fuva Brain Limited to Report Q3, 2026 Results on Feb 13, 2026Fuva Brain Limited announced that they will report Q3, 2026 results on Feb 13, 2026分析記事 • Nov 23Statutory Earnings May Not Be The Best Way To Understand Fuva Brain's (TSE:3927) True PositionDespite posting strong earnings, Fuva Brain Limited's ( TSE:3927 ) stock didn't move much over the last week. We looked...New Risk • Nov 23New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 41% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.3% average weekly change). High level of non-cash earnings (41% accrual ratio). Minor Risk Market cap is less than US$100m (JP¥4.28b market cap, or US$27.3m).Valuation Update With 7 Day Price Move • Nov 14Investor sentiment improves as stock rises 15%After last week's 15% share price gain to JP¥850, the stock trades at a trailing P/E ratio of 12.7x. Average trailing P/E is 22x in the Software industry in Japan. Total returns to shareholders of 25% over the past three years.分析記事 • Oct 02There's Been No Shortage Of Growth Recently For Fuva Brain's (TSE:3927) Returns On CapitalWhat trends should we look for it we want to identify stocks that can multiply in value over the long term? In a...お知らせ • Sep 01Fuva Brain Limited to Report Q2, 2026 Results on Nov 14, 2025Fuva Brain Limited announced that they will report Q2, 2026 results on Nov 14, 2025Reported Earnings • Aug 16First quarter 2026 earnings released: EPS: JP¥45.84 (vs JP¥0.57 loss in 1Q 2025)First quarter 2026 results: EPS: JP¥45.84 (up from JP¥0.57 loss in 1Q 2025). Revenue: JP¥1.30b (up 36% from 1Q 2025). Net income: JP¥245.0m (up JP¥248.0m from 1Q 2025). Profit margin: 19% (up from net loss in 1Q 2025). Over the last 3 years on average, earnings per share has increased by 83% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.Reported Earnings • Jun 29Full year 2025 earnings released: EPS: JP¥20.66 (vs JP¥5.16 in FY 2024)Full year 2025 results: EPS: JP¥20.66 (up from JP¥5.16 in FY 2024). Revenue: JP¥4.37b (up 42% from FY 2024). Net income: JP¥109.0m (up 304% from FY 2024). Profit margin: 2.5% (up from 0.9% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Jun 16Investor sentiment improves as stock rises 17%After last week's 17% share price gain to JP¥1,004, the stock trades at a trailing P/E ratio of 49.2x. Average trailing P/E is 21x in the Software industry in Japan. Total returns to shareholders of 34% over the past three years.お知らせ • Jun 10Fuva Brain Limited announced that it has received ¥14.963 million in funding from Modern Path LLCOn June 9, 2025, Fuva Brain Limited closed the transaction.お知らせ • May 31Fuva Brain Limited to Report Q1, 2026 Results on Aug 14, 2025Fuva Brain Limited announced that they will report Q1, 2026 results on Aug 14, 2025Valuation Update With 7 Day Price Move • May 27Investor sentiment improves as stock rises 15%After last week's 15% share price gain to JP¥864, the stock trades at a trailing P/E ratio of 44.4x. Average trailing P/E is 20x in the Software industry in Japan. Total returns to shareholders of 14% over the past three years.分析記事 • May 26Fuva Brain Limited (TSE:3927) Stock Rockets 31% As Investors Are Less Pessimistic Than ExpectedFuva Brain Limited ( TSE:3927 ) shareholders have had their patience rewarded with a 31% share price jump in the last...New Risk • May 25New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Japanese stocks, typically moving 9.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.4% average weekly change). High level of non-cash earnings (45% accrual ratio). Minor Risk Market cap is less than US$100m (JP¥4.32b market cap, or US$30.3m).Reported Earnings • May 21Full year 2025 earnings released: EPS: JP¥20.66 (vs JP¥5.16 in FY 2024)Full year 2025 results: EPS: JP¥20.66 (up from JP¥5.16 in FY 2024). Revenue: JP¥4.37b (up 42% from FY 2024). Net income: JP¥109.0m (up 304% from FY 2024). Profit margin: 2.5% (up from 0.9% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.分析記事 • May 20Returns On Capital At Fuva Brain (TSE:3927) Have Hit The BrakesTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...お知らせ • May 15Fuva Brain Limited, Annual General Meeting, Jun 24, 2025Fuva Brain Limited, Annual General Meeting, Jun 24, 2025.分析記事 • Apr 07Fuva Brain Limited (TSE:3927) Might Not Be As Mispriced As It Looks After Plunging 25%Fuva Brain Limited ( TSE:3927 ) shareholders that were waiting for something to happen have been dealt a blow with a...New Risk • Apr 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 6.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.6% average weekly change). Market cap is less than US$100m (JP¥2.73b market cap, or US$18.7m).Valuation Update With 7 Day Price Move • Apr 04Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to JP¥582, the stock trades at a trailing P/E ratio of 39.8x. Average trailing P/E is 19x in the Software industry in Japan. Total loss to shareholders of 19% over the past three years.分析記事 • Mar 17We Think Fuva Brain (TSE:3927) Can Stay On Top Of Its DebtWarren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...お知らせ • Mar 04Fuva Brain Limited to Report Fiscal Year 2025 Results on May 15, 2025Fuva Brain Limited announced that they will report fiscal year 2025 results at 3:00 PM, Tokyo Standard Time on May 15, 2025Reported Earnings • Feb 16Third quarter 2025 earnings released: EPS: JP¥5.26 (vs JP¥3.27 loss in 3Q 2024)Third quarter 2025 results: EPS: JP¥5.26 (up from JP¥3.27 loss in 3Q 2024). Revenue: JP¥1.21b (up 68% from 3Q 2024). Net income: JP¥28.0m (up JP¥45.0m from 3Q 2024). Profit margin: 2.3% (up from net loss in 3Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.お知らせ • Nov 30Fuva Brain Limited to Report Q3, 2025 Results on Feb 14, 2025Fuva Brain Limited announced that they will report Q3, 2025 results on Feb 14, 2025お知らせ • Aug 27Fuva Brain Limited to Report Q2, 2025 Results on Nov 14, 2024Fuva Brain Limited announced that they will report Q2, 2025 results on Nov 14, 2024Reported Earnings • Aug 11First quarter 2025 earnings released: JP¥0.57 loss per share (vs JP¥0.56 profit in 1Q 2024)First quarter 2025 results: JP¥0.57 loss per share (down from JP¥0.56 profit in 1Q 2024). Revenue: JP¥956.0m (up 29% from 1Q 2024). Net loss: JP¥3.00m (down 200% from profit in 1Q 2024).New Risk • Aug 02New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Japanese stocks, typically moving 7.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (7.4% average weekly change). Minor Risk Market cap is less than US$100m (JP¥5.44b market cap, or US$36.6m).Reported Earnings • May 21Full year 2024 earnings released: EPS: JP¥5.16 (vs JP¥4.87 in FY 2023)Full year 2024 results: EPS: JP¥5.16 (up from JP¥4.87 in FY 2023). Revenue: JP¥3.08b (up 32% from FY 2023). Net income: JP¥27.0m (up 3.8% from FY 2023). Profit margin: 0.9% (down from 1.1% in FY 2023). The decrease in margin was driven by higher expenses.お知らせ • May 17Fuva Brain Limited, Annual General Meeting, Jun 25, 2024Fuva Brain Limited, Annual General Meeting, Jun 25, 2024.お知らせ • Apr 07Fuva Brain Limited to Report Fiscal Year 2024 Results on May 15, 2024Fuva Brain Limited announced that they will report fiscal year 2024 results on May 15, 2024Reported Earnings • Feb 17Third quarter 2024 earnings released: JP¥3.27 loss per share (vs JP¥2.44 loss in 3Q 2023)Third quarter 2024 results: JP¥3.27 loss per share (further deteriorated from JP¥2.44 loss in 3Q 2023). Revenue: JP¥719.0m (up 42% from 3Q 2023). Net loss: JP¥17.0m (loss widened 31% from 3Q 2023).お知らせ • Nov 29Fuva Brain Limited to Report Q3, 2024 Results on Feb 14, 2024Fuva Brain Limited announced that they will report Q3, 2024 results on Feb 14, 2024Reported Earnings • Nov 19Second quarter 2024 earnings released: JP¥4.04 loss per share (vs JP¥5.06 profit in 2Q 2023)Second quarter 2024 results: JP¥4.04 loss per share (down from JP¥5.06 profit in 2Q 2023). Revenue: JP¥726.0m (up 30% from 2Q 2023). Net loss: JP¥21.0m (down 178% from profit in 2Q 2023).お知らせ • Sep 03Fuva Brain Limited to Report Q2, 2024 Results on Nov 14, 2023Fuva Brain Limited announced that they will report Q2, 2024 results on Nov 14, 2023Reported Earnings • Aug 13First quarter 2024 earnings released: EPS: JP¥0.56 (vs JP¥1.31 in 1Q 2023)First quarter 2024 results: EPS: JP¥0.56 (down from JP¥1.31 in 1Q 2023). Revenue: JP¥742.0m (up 33% from 1Q 2023). Net income: JP¥3.00m (down 57% from 1Q 2023). Profit margin: 0.4% (down from 1.3% in 1Q 2023). The decrease in margin was driven by higher expenses.お知らせ • Jun 03Fuva Brain Limited to Report Q1, 2024 Results on Aug 10, 2023Fuva Brain Limited announced that they will report Q1, 2024 results on Aug 10, 2023Reported Earnings • May 17Full year 2023 earnings released: EPS: JP¥4.87 (vs JP¥5.44 loss in FY 2022)Full year 2023 results: EPS: JP¥4.87 (up from JP¥5.44 loss in FY 2022). Revenue: JP¥2.34b (up 39% from FY 2022). Net income: JP¥26.0m (up JP¥55.0m from FY 2022). Profit margin: 1.1% (up from net loss in FY 2022). The move to profitability was driven by higher revenue.Valuation Update With 7 Day Price Move • May 17Investor sentiment improves as stock rises 17%After last week's 17% share price gain to JP¥699, the stock trades at a trailing P/E ratio of 56.5x. Average trailing P/E is 22x in the Software industry in Japan. Total loss to shareholders of 59% over the past three years.お知らせ • May 16Fuva Brain Limited (TSE:3927) announces an Equity Buyback for 170,000 shares, representing 3.18% for ¥100 million.Fuva Brain Limited (TSE:3927) announces a share repurchase program. Under the program, the company will repurchase up to 170,000 shares, representing 3.18% of its total shares outstanding (excluding treasury shares), for a total of ¥100 million. The purpose of the program is to enhance shareholder returns, improve capital efficiency and flexible implementation in response to changes in the business environment. The repurchase program is valid till November 15, 2023. As of March 31, 2023, the company had 5,338,838 shares outstanding (excluding treasury shares) and had 261,362 shares in treasury.Reported Earnings • Feb 16Third quarter 2023 earnings released: JP¥2.44 loss per share (vs JP¥8.43 profit in 3Q 2022)Third quarter 2023 results: JP¥2.44 loss per share (down from JP¥8.43 profit in 3Q 2022). Revenue: JP¥507.0m (down 3.8% from 3Q 2022). Net loss: JP¥13.0m (down 129% from profit in 3Q 2022).お知らせ • Nov 30+ 1 more updateFuva Brain Limited to Report Q3, 2023 Results on Feb 14, 2023Fuva Brain Limited announced that they will report Q3, 2023 results on Feb 14, 2023Reported Earnings • Nov 17Second quarter 2023 earnings released: EPS: JP¥5.06 (vs JP¥8.43 in 2Q 2022)Second quarter 2023 results: EPS: JP¥5.06 (down from JP¥8.43 in 2Q 2022). Revenue: JP¥559.0m (up 6.1% from 2Q 2022). Net income: JP¥27.0m (down 40% from 2Q 2022). Profit margin: 4.8% (down from 8.5% in 2Q 2022).Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Outside Director Takuya Uemura was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Sep 10Fuva Brain Limited to Report Q2, 2023 Results on Nov 14, 2022Fuva Brain Limited announced that they will report Q2, 2023 results on Nov 14, 2022お知らせ • Jun 03Fuva Brain Limited to Report Q1, 2023 Results on Aug 12, 2022Fuva Brain Limited announced that they will report Q1, 2023 results on Aug 12, 2022お知らせ • May 15Fuva Brain Limited, Annual General Meeting, Jun 27, 2022Fuva Brain Limited, Annual General Meeting, Jun 27, 2022.Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Outside Director Takuya Uemura was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Apr 08Fuva Brain Limited to Report Fiscal Year 2022 Results on May 13, 2022Fuva Brain Limited announced that they will report fiscal year 2022 results on May 13, 2022お知らせ • Feb 16Fuva Brain Limited announced that it has received ¥0.5 million in fundingOn February 15, 2022, Fuva Brain Limited closed the transaction.お知らせ • Feb 02Fuva Brain Limited announced that it expects to receive ¥0.5 million in fundingAhkun Co., Ltd. announced a private placement to issue 500 12th stock acquisition right securities at issue price of ¥100 per stock acquisition right for gross proceeds of ¥50,000 on January 31, 2022. The transaction will include participation from Nexpander Japan LLC for 500 stock acquisition rights. The transaction is expected to close on February 15, 2022. The transaction is through third party allotment. The stock acquisition right is convertible into 50,000 common stock of the company at an exercise price of ¥588 per share for gross proceeds of ¥29,400,000. The exercise period starts from the fiscal year ending March 2023 to the fiscal year ending March 2028. The company will pay approximate amount of deductions of JPY 26,450,000 including issuance costs of JPY 3,000,000. The transaction has been approved by the board of directors of the company.Reported Earnings • May 17Full year 2021 earnings released: JP¥34.14 loss per share (vs JP¥16.13 loss in FY 2020)The company reported a soft full year result with increased losses and weaker control over costs, although revenues improved. Full year 2021 results: Revenue: JP¥1.08b (up 3.4% from FY 2020). Net loss: JP¥174.0m (loss widened 156% from FY 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 83 percentage points per year, which is a significant difference in performance.お知らせ • Mar 04Fuva Brain Limited to Report Fiscal Year 2021 Results on May 14, 2021Fuva Brain Limited announced that they will report fiscal year 2021 results on May 14, 2021Is New 90 Day High Low • Feb 15New 90-day low: JP¥873The company is down 18% from its price of JP¥1,059 on 17 November 2020. The Japanese market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is up 5.0% over the same period.Reported Earnings • Feb 14Third quarter 2021 earnings released: JP¥6.27 loss per share (vs JP¥0.95 profit in 3Q 2020)The company reported a poor third quarter result with weaker earnings, revenues and control over costs. Third quarter 2021 results: Revenue: JP¥257.0m (down 13% from 3Q 2020). Net loss: JP¥33.0m (down JP¥37.0m from profit in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 2% per year whereas the company’s share price has increased by 1% per year.Is New 90 Day High Low • Dec 22New 90-day low: JP¥899The company is down 26% from its price of JP¥1,212 on 23 September 2020. The Japanese market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is up 2.0% over the same period.Is New 90 Day High Low • Dec 07New 90-day low: JP¥943The company is down 16% from its price of JP¥1,128 on 08 September 2020. The Japanese market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is up 6.0% over the same period.お知らせ • Sep 04Fuva Brain Limited to Report Q2, 2021 Results on Nov 12, 2020Fuva Brain Limited announced that they will report Q2, 2021 results on Nov 12, 2020収支内訳Fuva Brain の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史TSE:3927 収益、費用、利益 ( )JPY Millions日付収益収益G+A経費研究開発費31 Mar 265,6413081,355031 Dec 255,4074221,228030 Sep 255,1854051,204030 Jun 254,7203571,177031 Mar 254,3731091,116031 Dec 243,978821,088030 Sep 243,486371,038030 Jun 243,289211,010031 Mar 243,07527990031 Dec 232,899-30989030 Sep 232,687-26942030 Jun 232,52022892031 Mar 232,33826842031 Dec 222,15366802030 Sep 222,03359796030 Jun 221,8623799031 Mar 221,682-298030質の高い収益: 3927には¥379.0M } という大きな 一回限りの 利益があり、過去 12 か月の財務実績が31st March, 2026に影響を及ぼしています。利益率の向上: 3927の現在の純利益率 (5.5%)は、昨年(2.5%)よりも高くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: 3927の収益は過去 5 年間で年間80.9%増加しました。成長の加速: 3927の過去 1 年間の収益成長率 ( 182.6% ) は、5 年間の平均 ( 年間80.9%を上回っています。収益対業界: 3927の過去 1 年間の収益成長率 ( 182.6% ) はSoftware業界16.8%を上回りました。株主資本利益率高いROE: 3927の 自己資本利益率 ( 14.6% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YSoftware 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/21 02:58終値2026/05/21 00:00収益2026/03/31年間収益2026/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Fuva Brain Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。2 アナリスト機関Kaname FujitaIchiyoshi Research Institute Inc.Toru KoboriMarusan Securities Co. Ltd.
Reported Earnings • May 20Full year 2026 earnings released: EPS: JP¥57.63 (vs JP¥20.66 in FY 2025)Full year 2026 results: EPS: JP¥57.63 (up from JP¥20.66 in FY 2025). Revenue: JP¥5.64b (up 29% from FY 2025). Net income: JP¥308.0m (up 183% from FY 2025). Profit margin: 5.5% (up from 2.5% in FY 2025). Over the last 3 years on average, earnings per share has increased by 103% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Feb 16Third quarter 2026 earnings released: EPS: JP¥8.42 (vs JP¥5.26 in 3Q 2025)Third quarter 2026 results: EPS: JP¥8.42 (up from JP¥5.26 in 3Q 2025). Revenue: JP¥1.43b (up 18% from 3Q 2025). Net income: JP¥45.0m (up 61% from 3Q 2025). Profit margin: 3.1% (up from 2.3% in 3Q 2025). Over the last 3 years on average, earnings per share has increased by 105% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth.
お知らせ • Dec 02Fuva Brain Limited to Report Q3, 2026 Results on Feb 13, 2026Fuva Brain Limited announced that they will report Q3, 2026 results on Feb 13, 2026
分析記事 • Nov 23Statutory Earnings May Not Be The Best Way To Understand Fuva Brain's (TSE:3927) True PositionDespite posting strong earnings, Fuva Brain Limited's ( TSE:3927 ) stock didn't move much over the last week. We looked...
お知らせ • Sep 01Fuva Brain Limited to Report Q2, 2026 Results on Nov 14, 2025Fuva Brain Limited announced that they will report Q2, 2026 results on Nov 14, 2025
Reported Earnings • Aug 16First quarter 2026 earnings released: EPS: JP¥45.84 (vs JP¥0.57 loss in 1Q 2025)First quarter 2026 results: EPS: JP¥45.84 (up from JP¥0.57 loss in 1Q 2025). Revenue: JP¥1.30b (up 36% from 1Q 2025). Net income: JP¥245.0m (up JP¥248.0m from 1Q 2025). Profit margin: 19% (up from net loss in 1Q 2025). Over the last 3 years on average, earnings per share has increased by 83% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.
Reported Earnings • May 20Full year 2026 earnings released: EPS: JP¥57.63 (vs JP¥20.66 in FY 2025)Full year 2026 results: EPS: JP¥57.63 (up from JP¥20.66 in FY 2025). Revenue: JP¥5.64b (up 29% from FY 2025). Net income: JP¥308.0m (up 183% from FY 2025). Profit margin: 5.5% (up from 2.5% in FY 2025). Over the last 3 years on average, earnings per share has increased by 103% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.
New Risk • May 18New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Japanese stocks, typically moving 9.5% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (9.5% average weekly change). Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (JP¥5.34b market cap, or US$33.7m).
お知らせ • May 15Fuva Brain Limited, Annual General Meeting, Jun 24, 2026Fuva Brain Limited, Annual General Meeting, Jun 24, 2026.
Valuation Update With 7 Day Price Move • May 11Investor sentiment improves as stock rises 17%After last week's 17% share price gain to JP¥1,197, the stock trades at a trailing P/E ratio of 15.2x. Average trailing P/E is 17x in the Software industry in Japan. Total returns to shareholders of 101% over the past three years.
Valuation Update With 7 Day Price Move • Mar 10Investor sentiment improves as stock rises 25%After last week's 25% share price gain to JP¥1,049, the stock trades at a trailing P/E ratio of 13.3x. Average trailing P/E is 17x in the Software industry in Japan. Total returns to shareholders of 69% over the past three years.
Reported Earnings • Feb 16Third quarter 2026 earnings released: EPS: JP¥8.42 (vs JP¥5.26 in 3Q 2025)Third quarter 2026 results: EPS: JP¥8.42 (up from JP¥5.26 in 3Q 2025). Revenue: JP¥1.43b (up 18% from 3Q 2025). Net income: JP¥45.0m (up 61% from 3Q 2025). Profit margin: 3.1% (up from 2.3% in 3Q 2025). Over the last 3 years on average, earnings per share has increased by 105% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth.
お知らせ • Dec 02Fuva Brain Limited to Report Q3, 2026 Results on Feb 13, 2026Fuva Brain Limited announced that they will report Q3, 2026 results on Feb 13, 2026
分析記事 • Nov 23Statutory Earnings May Not Be The Best Way To Understand Fuva Brain's (TSE:3927) True PositionDespite posting strong earnings, Fuva Brain Limited's ( TSE:3927 ) stock didn't move much over the last week. We looked...
New Risk • Nov 23New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 41% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.3% average weekly change). High level of non-cash earnings (41% accrual ratio). Minor Risk Market cap is less than US$100m (JP¥4.28b market cap, or US$27.3m).
Valuation Update With 7 Day Price Move • Nov 14Investor sentiment improves as stock rises 15%After last week's 15% share price gain to JP¥850, the stock trades at a trailing P/E ratio of 12.7x. Average trailing P/E is 22x in the Software industry in Japan. Total returns to shareholders of 25% over the past three years.
分析記事 • Oct 02There's Been No Shortage Of Growth Recently For Fuva Brain's (TSE:3927) Returns On CapitalWhat trends should we look for it we want to identify stocks that can multiply in value over the long term? In a...
お知らせ • Sep 01Fuva Brain Limited to Report Q2, 2026 Results on Nov 14, 2025Fuva Brain Limited announced that they will report Q2, 2026 results on Nov 14, 2025
Reported Earnings • Aug 16First quarter 2026 earnings released: EPS: JP¥45.84 (vs JP¥0.57 loss in 1Q 2025)First quarter 2026 results: EPS: JP¥45.84 (up from JP¥0.57 loss in 1Q 2025). Revenue: JP¥1.30b (up 36% from 1Q 2025). Net income: JP¥245.0m (up JP¥248.0m from 1Q 2025). Profit margin: 19% (up from net loss in 1Q 2025). Over the last 3 years on average, earnings per share has increased by 83% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Jun 29Full year 2025 earnings released: EPS: JP¥20.66 (vs JP¥5.16 in FY 2024)Full year 2025 results: EPS: JP¥20.66 (up from JP¥5.16 in FY 2024). Revenue: JP¥4.37b (up 42% from FY 2024). Net income: JP¥109.0m (up 304% from FY 2024). Profit margin: 2.5% (up from 0.9% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Jun 16Investor sentiment improves as stock rises 17%After last week's 17% share price gain to JP¥1,004, the stock trades at a trailing P/E ratio of 49.2x. Average trailing P/E is 21x in the Software industry in Japan. Total returns to shareholders of 34% over the past three years.
お知らせ • Jun 10Fuva Brain Limited announced that it has received ¥14.963 million in funding from Modern Path LLCOn June 9, 2025, Fuva Brain Limited closed the transaction.
お知らせ • May 31Fuva Brain Limited to Report Q1, 2026 Results on Aug 14, 2025Fuva Brain Limited announced that they will report Q1, 2026 results on Aug 14, 2025
Valuation Update With 7 Day Price Move • May 27Investor sentiment improves as stock rises 15%After last week's 15% share price gain to JP¥864, the stock trades at a trailing P/E ratio of 44.4x. Average trailing P/E is 20x in the Software industry in Japan. Total returns to shareholders of 14% over the past three years.
分析記事 • May 26Fuva Brain Limited (TSE:3927) Stock Rockets 31% As Investors Are Less Pessimistic Than ExpectedFuva Brain Limited ( TSE:3927 ) shareholders have had their patience rewarded with a 31% share price jump in the last...
New Risk • May 25New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Japanese stocks, typically moving 9.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.4% average weekly change). High level of non-cash earnings (45% accrual ratio). Minor Risk Market cap is less than US$100m (JP¥4.32b market cap, or US$30.3m).
Reported Earnings • May 21Full year 2025 earnings released: EPS: JP¥20.66 (vs JP¥5.16 in FY 2024)Full year 2025 results: EPS: JP¥20.66 (up from JP¥5.16 in FY 2024). Revenue: JP¥4.37b (up 42% from FY 2024). Net income: JP¥109.0m (up 304% from FY 2024). Profit margin: 2.5% (up from 0.9% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.
分析記事 • May 20Returns On Capital At Fuva Brain (TSE:3927) Have Hit The BrakesTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...
お知らせ • May 15Fuva Brain Limited, Annual General Meeting, Jun 24, 2025Fuva Brain Limited, Annual General Meeting, Jun 24, 2025.
分析記事 • Apr 07Fuva Brain Limited (TSE:3927) Might Not Be As Mispriced As It Looks After Plunging 25%Fuva Brain Limited ( TSE:3927 ) shareholders that were waiting for something to happen have been dealt a blow with a...
New Risk • Apr 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 6.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.6% average weekly change). Market cap is less than US$100m (JP¥2.73b market cap, or US$18.7m).
Valuation Update With 7 Day Price Move • Apr 04Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to JP¥582, the stock trades at a trailing P/E ratio of 39.8x. Average trailing P/E is 19x in the Software industry in Japan. Total loss to shareholders of 19% over the past three years.
分析記事 • Mar 17We Think Fuva Brain (TSE:3927) Can Stay On Top Of Its DebtWarren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
お知らせ • Mar 04Fuva Brain Limited to Report Fiscal Year 2025 Results on May 15, 2025Fuva Brain Limited announced that they will report fiscal year 2025 results at 3:00 PM, Tokyo Standard Time on May 15, 2025
Reported Earnings • Feb 16Third quarter 2025 earnings released: EPS: JP¥5.26 (vs JP¥3.27 loss in 3Q 2024)Third quarter 2025 results: EPS: JP¥5.26 (up from JP¥3.27 loss in 3Q 2024). Revenue: JP¥1.21b (up 68% from 3Q 2024). Net income: JP¥28.0m (up JP¥45.0m from 3Q 2024). Profit margin: 2.3% (up from net loss in 3Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
お知らせ • Nov 30Fuva Brain Limited to Report Q3, 2025 Results on Feb 14, 2025Fuva Brain Limited announced that they will report Q3, 2025 results on Feb 14, 2025
お知らせ • Aug 27Fuva Brain Limited to Report Q2, 2025 Results on Nov 14, 2024Fuva Brain Limited announced that they will report Q2, 2025 results on Nov 14, 2024
Reported Earnings • Aug 11First quarter 2025 earnings released: JP¥0.57 loss per share (vs JP¥0.56 profit in 1Q 2024)First quarter 2025 results: JP¥0.57 loss per share (down from JP¥0.56 profit in 1Q 2024). Revenue: JP¥956.0m (up 29% from 1Q 2024). Net loss: JP¥3.00m (down 200% from profit in 1Q 2024).
New Risk • Aug 02New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Japanese stocks, typically moving 7.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (7.4% average weekly change). Minor Risk Market cap is less than US$100m (JP¥5.44b market cap, or US$36.6m).
Reported Earnings • May 21Full year 2024 earnings released: EPS: JP¥5.16 (vs JP¥4.87 in FY 2023)Full year 2024 results: EPS: JP¥5.16 (up from JP¥4.87 in FY 2023). Revenue: JP¥3.08b (up 32% from FY 2023). Net income: JP¥27.0m (up 3.8% from FY 2023). Profit margin: 0.9% (down from 1.1% in FY 2023). The decrease in margin was driven by higher expenses.
お知らせ • May 17Fuva Brain Limited, Annual General Meeting, Jun 25, 2024Fuva Brain Limited, Annual General Meeting, Jun 25, 2024.
お知らせ • Apr 07Fuva Brain Limited to Report Fiscal Year 2024 Results on May 15, 2024Fuva Brain Limited announced that they will report fiscal year 2024 results on May 15, 2024
Reported Earnings • Feb 17Third quarter 2024 earnings released: JP¥3.27 loss per share (vs JP¥2.44 loss in 3Q 2023)Third quarter 2024 results: JP¥3.27 loss per share (further deteriorated from JP¥2.44 loss in 3Q 2023). Revenue: JP¥719.0m (up 42% from 3Q 2023). Net loss: JP¥17.0m (loss widened 31% from 3Q 2023).
お知らせ • Nov 29Fuva Brain Limited to Report Q3, 2024 Results on Feb 14, 2024Fuva Brain Limited announced that they will report Q3, 2024 results on Feb 14, 2024
Reported Earnings • Nov 19Second quarter 2024 earnings released: JP¥4.04 loss per share (vs JP¥5.06 profit in 2Q 2023)Second quarter 2024 results: JP¥4.04 loss per share (down from JP¥5.06 profit in 2Q 2023). Revenue: JP¥726.0m (up 30% from 2Q 2023). Net loss: JP¥21.0m (down 178% from profit in 2Q 2023).
お知らせ • Sep 03Fuva Brain Limited to Report Q2, 2024 Results on Nov 14, 2023Fuva Brain Limited announced that they will report Q2, 2024 results on Nov 14, 2023
Reported Earnings • Aug 13First quarter 2024 earnings released: EPS: JP¥0.56 (vs JP¥1.31 in 1Q 2023)First quarter 2024 results: EPS: JP¥0.56 (down from JP¥1.31 in 1Q 2023). Revenue: JP¥742.0m (up 33% from 1Q 2023). Net income: JP¥3.00m (down 57% from 1Q 2023). Profit margin: 0.4% (down from 1.3% in 1Q 2023). The decrease in margin was driven by higher expenses.
お知らせ • Jun 03Fuva Brain Limited to Report Q1, 2024 Results on Aug 10, 2023Fuva Brain Limited announced that they will report Q1, 2024 results on Aug 10, 2023
Reported Earnings • May 17Full year 2023 earnings released: EPS: JP¥4.87 (vs JP¥5.44 loss in FY 2022)Full year 2023 results: EPS: JP¥4.87 (up from JP¥5.44 loss in FY 2022). Revenue: JP¥2.34b (up 39% from FY 2022). Net income: JP¥26.0m (up JP¥55.0m from FY 2022). Profit margin: 1.1% (up from net loss in FY 2022). The move to profitability was driven by higher revenue.
Valuation Update With 7 Day Price Move • May 17Investor sentiment improves as stock rises 17%After last week's 17% share price gain to JP¥699, the stock trades at a trailing P/E ratio of 56.5x. Average trailing P/E is 22x in the Software industry in Japan. Total loss to shareholders of 59% over the past three years.
お知らせ • May 16Fuva Brain Limited (TSE:3927) announces an Equity Buyback for 170,000 shares, representing 3.18% for ¥100 million.Fuva Brain Limited (TSE:3927) announces a share repurchase program. Under the program, the company will repurchase up to 170,000 shares, representing 3.18% of its total shares outstanding (excluding treasury shares), for a total of ¥100 million. The purpose of the program is to enhance shareholder returns, improve capital efficiency and flexible implementation in response to changes in the business environment. The repurchase program is valid till November 15, 2023. As of March 31, 2023, the company had 5,338,838 shares outstanding (excluding treasury shares) and had 261,362 shares in treasury.
Reported Earnings • Feb 16Third quarter 2023 earnings released: JP¥2.44 loss per share (vs JP¥8.43 profit in 3Q 2022)Third quarter 2023 results: JP¥2.44 loss per share (down from JP¥8.43 profit in 3Q 2022). Revenue: JP¥507.0m (down 3.8% from 3Q 2022). Net loss: JP¥13.0m (down 129% from profit in 3Q 2022).
お知らせ • Nov 30+ 1 more updateFuva Brain Limited to Report Q3, 2023 Results on Feb 14, 2023Fuva Brain Limited announced that they will report Q3, 2023 results on Feb 14, 2023
Reported Earnings • Nov 17Second quarter 2023 earnings released: EPS: JP¥5.06 (vs JP¥8.43 in 2Q 2022)Second quarter 2023 results: EPS: JP¥5.06 (down from JP¥8.43 in 2Q 2022). Revenue: JP¥559.0m (up 6.1% from 2Q 2022). Net income: JP¥27.0m (down 40% from 2Q 2022). Profit margin: 4.8% (down from 8.5% in 2Q 2022).
Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Outside Director Takuya Uemura was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Sep 10Fuva Brain Limited to Report Q2, 2023 Results on Nov 14, 2022Fuva Brain Limited announced that they will report Q2, 2023 results on Nov 14, 2022
お知らせ • Jun 03Fuva Brain Limited to Report Q1, 2023 Results on Aug 12, 2022Fuva Brain Limited announced that they will report Q1, 2023 results on Aug 12, 2022
お知らせ • May 15Fuva Brain Limited, Annual General Meeting, Jun 27, 2022Fuva Brain Limited, Annual General Meeting, Jun 27, 2022.
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Outside Director Takuya Uemura was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Apr 08Fuva Brain Limited to Report Fiscal Year 2022 Results on May 13, 2022Fuva Brain Limited announced that they will report fiscal year 2022 results on May 13, 2022
お知らせ • Feb 16Fuva Brain Limited announced that it has received ¥0.5 million in fundingOn February 15, 2022, Fuva Brain Limited closed the transaction.
お知らせ • Feb 02Fuva Brain Limited announced that it expects to receive ¥0.5 million in fundingAhkun Co., Ltd. announced a private placement to issue 500 12th stock acquisition right securities at issue price of ¥100 per stock acquisition right for gross proceeds of ¥50,000 on January 31, 2022. The transaction will include participation from Nexpander Japan LLC for 500 stock acquisition rights. The transaction is expected to close on February 15, 2022. The transaction is through third party allotment. The stock acquisition right is convertible into 50,000 common stock of the company at an exercise price of ¥588 per share for gross proceeds of ¥29,400,000. The exercise period starts from the fiscal year ending March 2023 to the fiscal year ending March 2028. The company will pay approximate amount of deductions of JPY 26,450,000 including issuance costs of JPY 3,000,000. The transaction has been approved by the board of directors of the company.
Reported Earnings • May 17Full year 2021 earnings released: JP¥34.14 loss per share (vs JP¥16.13 loss in FY 2020)The company reported a soft full year result with increased losses and weaker control over costs, although revenues improved. Full year 2021 results: Revenue: JP¥1.08b (up 3.4% from FY 2020). Net loss: JP¥174.0m (loss widened 156% from FY 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 83 percentage points per year, which is a significant difference in performance.
お知らせ • Mar 04Fuva Brain Limited to Report Fiscal Year 2021 Results on May 14, 2021Fuva Brain Limited announced that they will report fiscal year 2021 results on May 14, 2021
Is New 90 Day High Low • Feb 15New 90-day low: JP¥873The company is down 18% from its price of JP¥1,059 on 17 November 2020. The Japanese market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is up 5.0% over the same period.
Reported Earnings • Feb 14Third quarter 2021 earnings released: JP¥6.27 loss per share (vs JP¥0.95 profit in 3Q 2020)The company reported a poor third quarter result with weaker earnings, revenues and control over costs. Third quarter 2021 results: Revenue: JP¥257.0m (down 13% from 3Q 2020). Net loss: JP¥33.0m (down JP¥37.0m from profit in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 2% per year whereas the company’s share price has increased by 1% per year.
Is New 90 Day High Low • Dec 22New 90-day low: JP¥899The company is down 26% from its price of JP¥1,212 on 23 September 2020. The Japanese market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is up 2.0% over the same period.
Is New 90 Day High Low • Dec 07New 90-day low: JP¥943The company is down 16% from its price of JP¥1,128 on 08 September 2020. The Japanese market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is up 6.0% over the same period.
お知らせ • Sep 04Fuva Brain Limited to Report Q2, 2021 Results on Nov 12, 2020Fuva Brain Limited announced that they will report Q2, 2021 results on Nov 12, 2020